(+)-Rose oxide injections (50-100mg/kg, 25mg/kg not reaching significance on any parameter) noted dose-dependent reductions in biomarkers of inflammation in rats exposed to a formalin test (100mg/kg of comparable potency to 10mg/kg Indomethacin), a complete Freund's adjuvant (CFA; 50-100mg/kg being comparable to 2mg/kg Dexamethasone) and carrageenan-induced paw edema (50-100mg/kg being comparable to Dexamethasone) while being noted to reduce circulating IL-1β in mice treated with CFA to a similar level as Dexamethasone; Rose oxide failed to at all influence TNF-α concentrations, and exhibited an myeloperoxidase (MPO) reducing ability at all doses.[4]
Has shown some anti-inflammatory properties (moderate to high potency) following injections of isolated Rose oxide in rats
In a trial where persons were given rose aroma in a blinded manner, the aroma of Rose as well as the aromas of Lavender or Patchouli all failed to significantly influence immunological markers of neutrophil actions.[8]
A trend was noted for the above relaxing herbs to reduce Plasminogen activation inhibitor 1 (PAI-1) activity, but this failed to reach statistical significance for the whole group (reached significance for a female subset).[8] The opposite trend (an increase in PAI-1) was noted for the stimulatory aromas of Grapefruit, Fennel, and Pepper.[8]
Aside from possible weak influences on PAI-1 in females, there does not appear to be substantial human evidence linking immunity to the aroma of a rose